IL-17 and IL-13, two types of interleukin family, are common research subjects in the pathogenesis of asthma and are often studied as therapeutic targets for asthma (Ntontsi et al., 2018; Ramakrishnan et al., 2019). Here, IL13 is linked to asthma.